Literature DB >> 2671596

Adverse effects of anabolic steroids.

R C Hickson1, K L Ball, M T Falduto.   

Abstract

Anabolic steroids are used therapeutically for various disorders and as ergogenic aids by athletes to augment strength, muscular development, and to enhance performance. There is a wide range of concomitant temporary and permanent adverse effects with steroid administration. Several well-documented adverse actions of these hormones may develop rapidly within several weeks or less (i.e. altered reproductive function) or require up to several years of steroid intake (i.e. liver carcinoma). More recent studies indicate that glucose intolerance, insulin resistance, increased cardiovascular disease risk profiles, cerebral dangers, musculoskeletal injuries, prostate cancer, psychosis and schizophrenic episodes, among others, accompany anabolic steroid intake. There is, at present, no evidence to support the claim that athletes are less susceptible to adverse effects than those individuals receiving hormone treatment in a clinical setting. Based on the available information which has accumulated primarily from cross-sectional, short term longitudinal, and case studies, there is a need: (a) to develop a comprehensive battery of specific and sensitive markers of adverse effects, particularly those that would be able to detect the onset of adverse actions; and (b) to conduct controlled long term longitudinal studies in order to fully understand the extensiveness and mechanisms involved in the occurrence of adverse effects.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2671596     DOI: 10.1007/bf03259912

Source DB:  PubMed          Journal:  Med Toxicol Adverse Drug Exp        ISSN: 0113-5244


  165 in total

1.  The use of anabolic steroids by athletes to increase body weight and strength.

Authors:  A J Tahmindjis
Journal:  Med J Aust       Date:  1976-06-26       Impact factor: 7.738

2.  Steroid structure and androgenic activity. Specificities involved in the receptor binding and nuclear retention of various androgens.

Authors:  S Liao; T Liang; S Fang; E Castañeda; T C Shao
Journal:  J Biol Chem       Date:  1973-09-10       Impact factor: 5.157

3.  Enhanced linear growth responses in hypopituitary dwarfs treated with growth hormone plus androgen versus growth hormone alone.

Authors:  M H MacGillivray; M Kolotkin; R W Munschauer
Journal:  Pediatr Res       Date:  1974-02       Impact factor: 3.756

4.  Erythropoietic response of dialyzed patients to testosterone administration.

Authors:  J R Richardson; M B Weinstein
Journal:  Ann Intern Med       Date:  1970-09       Impact factor: 25.391

5.  Adenocarcinoma of prostate in 40-year-old body-builder.

Authors:  J T Roberts; D M Essenhigh
Journal:  Lancet       Date:  1986-09-27       Impact factor: 79.321

6.  Testosterone-mediated sexual dimorphism of the rodent heart. Ventricular lysosomes, mitochondria, and cell growth are modulated by androgens.

Authors:  H Koenig; A Goldstone; C Y Lu
Journal:  Circ Res       Date:  1982-06       Impact factor: 17.367

7.  HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study.

Authors:  W P Castelli; J T Doyle; T Gordon; C G Hames; M C Hjortland; S B Hulley; A Kagan; W J Zukel
Journal:  Circulation       Date:  1977-05       Impact factor: 29.690

8.  Insulin resistance and diminished glucose tolerance in powerlifters ingesting anabolic steroids.

Authors:  J C Cohen; R Hickman
Journal:  J Clin Endocrinol Metab       Date:  1987-05       Impact factor: 5.958

9.  The distribution of plasma lipoproteins in middle-aged male runners.

Authors:  P D Wood; W Haskell; H Klein; S Lewis; M P Stern; J W Farquhar
Journal:  Metabolism       Date:  1976-11       Impact factor: 8.694

10.  [Testosteron treatment of excessively tall boys (author's transl)].

Authors:  J H Brämswig; G Schellong; H J Borger; H Breu
Journal:  Dtsch Med Wochenschr       Date:  1981-12-04       Impact factor: 0.628

View more
  10 in total

Review 1.  Urine nandrolone metabolites: false positive doping test?

Authors:  R M N Kohler; M I Lambert
Journal:  Br J Sports Med       Date:  2002-10       Impact factor: 13.800

Review 2.  Enhancement of athletic performance with drugs. An overview.

Authors:  J C Wagner
Journal:  Sports Med       Date:  1991-10       Impact factor: 11.136

Review 3.  Psychological and behavioural effects of endogenous testosterone levels and anabolic-androgenic steroids among males. A review.

Authors:  M S Bahrke; C E Yesalis; J E Wright
Journal:  Sports Med       Date:  1990-11       Impact factor: 11.136

Review 4.  Anabolic steroids: a review for the clinician.

Authors:  Eric C Kutscher; Brian C Lund; Paul J Perry
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 5.  Recent developments in the toxicology of anabolic steroids.

Authors:  S Graham; M Kennedy
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

Review 6.  Anabolic steroid use: patterns of use and detection of doping.

Authors:  Michael R Graham; Bruce Davies; Fergal M Grace; Andrew Kicman; Julien S Baker
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

7.  Identification of black market products and potential doping agents in Germany 2010-2013.

Authors:  Oliver Krug; Andreas Thomas; Katja Walpurgis; Thomas Piper; Gerd Sigmund; Wilhelm Schänzer; Tim Laussmann; Mario Thevis
Journal:  Eur J Clin Pharmacol       Date:  2014-08-30       Impact factor: 2.953

8.  Prevalence of anabolic steroid use among illinois high school students.

Authors:  L D Tuttle; G L Gaa; E H Griffith; B R Cahill
Journal:  J Athl Train       Date:  1994-09       Impact factor: 2.860

Review 9.  Anabolic-Androgenic Steroid Misuse: Mechanisms, Patterns of Misuse, User Typology, and Adverse Effects.

Authors:  Jack B Ding; Marcus Z Ng; Steven S Huang; Mark Ding; Kevin Hu
Journal:  J Sports Med (Hindawi Publ Corp)       Date:  2021-12-10

10.  The interaction effects of resistance training and sustanon abuse on liver antioxidant activities and serum enzymes in male rats.

Authors:  Hamid Arazi; Siavash Rahmati; Hosein Ghafoori
Journal:  Interv Med Appl Sci       Date:  2017-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.